Zhengyang Guo

559 total citations
26 papers, 390 citations indexed

About

Zhengyang Guo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Zhengyang Guo has authored 26 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Zhengyang Guo's work include Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Zhengyang Guo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Zhengyang Guo collaborates with scholars based in China, United States and Macao. Zhengyang Guo's co-authors include Lixiang Xue, Huiying Liu, Hai Bi, Lulin Ma, Jiaqi Huang, Xiao Huo, Changtao Jiang, Jianling Yang, Xiangmei Chen and Fengmin Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Zhengyang Guo

23 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengyang Guo China 13 271 113 70 44 42 26 390
Xiaoqin Zheng China 13 156 0.6× 57 0.5× 74 1.1× 41 0.9× 47 1.1× 27 397
Yinying Lu China 11 238 0.9× 114 1.0× 47 0.7× 69 1.6× 48 1.1× 35 445
Hongfei Chen China 11 310 1.1× 66 0.6× 52 0.7× 16 0.4× 44 1.0× 23 454
Haosheng Tang China 9 296 1.1× 129 1.1× 57 0.8× 72 1.6× 58 1.4× 9 430
Ian M. Cartwright United States 13 196 0.7× 49 0.4× 70 1.0× 42 1.0× 46 1.1× 31 371
Fengqi Hao China 10 317 1.2× 139 1.2× 113 1.6× 30 0.7× 63 1.5× 20 515
Mladen Paradžik Croatia 9 174 0.6× 55 0.5× 123 1.8× 66 1.5× 25 0.6× 16 424
Valesca Anschau Brazil 7 155 0.6× 49 0.4× 77 1.1× 48 1.1× 39 0.9× 12 292
Manman Su China 12 202 0.7× 114 1.0× 49 0.7× 38 0.9× 18 0.4× 30 355

Countries citing papers authored by Zhengyang Guo

Since Specialization
Citations

This map shows the geographic impact of Zhengyang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyang Guo more than expected).

Fields of papers citing papers by Zhengyang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengyang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyang Guo. The network helps show where Zhengyang Guo may publish in the future.

Co-authorship network of co-authors of Zhengyang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengyang Guo. A scholar is included among the top collaborators of Zhengyang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengyang Guo. Zhengyang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Zhengyang, Yunyun Guo, Xiao Huo, et al.. (2025). Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression. Journal of Ovarian Research. 18(1). 180–180.
2.
Li, Ming, Zhe Chen, Zhengyang Guo, et al.. (2025). Alpha-tubulin tails regulate axoneme differentiation. Proceedings of the National Academy of Sciences. 122(15). e2414731122–e2414731122. 1 indexed citations
3.
Ma, Shuai, Hao Wang, Xiaotong Yu, et al.. (2025). Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy. Frontiers in Immunology. 16. 1603855–1603855. 2 indexed citations
4.
Guo, Yunyun, et al.. (2025). One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy. Cancer and Metastasis Reviews. 44(4). 91–91.
5.
Guo, Zhengyang, Yuqing Wang, Jiagui Song, et al.. (2025). Differential regulation of FADS2 by EZH2 reveals a metabolic vulnerability in ovarian cancer treatment. EBioMedicine. 119. 105879–105879.
6.
Liu, Chunhua, Zhengyang Guo, Yuying Zhang, et al.. (2024). Administration of Atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism. Behavioural Brain Research. 469. 115052–115052. 2 indexed citations
7.
Huang, Jiaqi, Qianqian Yin, Yuqing Wang, et al.. (2024). EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer. Advanced Science. 11(23). e2308045–e2308045. 20 indexed citations
8.
Guo, Zhengyang, Jiaqi Huang, Xiao Huo, et al.. (2024). Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin. Science China Life Sciences. 67(6). 1226–1241. 11 indexed citations
9.
Guo, Zhengyang, Xiao Huo, Xianlong Li, Changtao Jiang, & Lixiang Xue. (2023). Advances in regulation and function of stearoyl-CoA desaturase 1 in cancer, from bench to bed. Science China Life Sciences. 66(12). 2773–2785. 18 indexed citations
10.
Ji, Kai‐Long, et al.. (2023). Natural Geranylated Sulfur‐Containing Amides with Inhibitory Effect on Th17 Differentiation. Chemistry & Biodiversity. 20(6). e202300373–e202300373. 2 indexed citations
11.
Guo, Zhengyang, Xiao Huo, Yueqing Gong, et al.. (2022). Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor. EBioMedicine. 77. 103872–103872. 33 indexed citations
12.
Li, Chen, Jiagui Song, Zhengyang Guo, et al.. (2022). EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment. Frontiers in Immunology. 13. 857808–857808. 35 indexed citations
13.
Liu, Juan, Yuxin Zhuang, Jian‐Lin Wu, et al.. (2021). IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα. Acta Pharmaceutica Sinica B. 12(2). 651–664. 15 indexed citations
14.
Huang, Jiaqi, Jie Zhang, Zhengyang Guo, et al.. (2021). Easy or Not—The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity. Frontiers in Immunology. 12. 741302–741302. 19 indexed citations
15.
Shu, Shi, Mingchen Liu, Hui Liu, et al.. (2020). Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4α expression. Antiviral Research. 176. 104745–104745. 5 indexed citations
16.
Bi, Hai, et al.. (2020). The key points in the pre-analytical procedures of blood and urine samples in metabolomics studies. Metabolomics. 16(6). 68–68. 51 indexed citations
17.
Yang, Jianling, Zhengyang Guo, Xu Liu, et al.. (2020). Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model. Frontiers in Pharmacology. 11. 574720–574720. 30 indexed citations
18.
Chen, Jing, Zhengyang Guo, Zhongdong Liu, et al.. (2019). Influence of design probe and sequence mismatches on the efficiency of fluorescent RPA. World Journal of Microbiology and Biotechnology. 35(6). 95–95. 33 indexed citations
19.
Chen, J. Paul, Xiaoqing Liu, Jing Chen, et al.. (2019). Development of a Rapid Test Method for Salmonella enterica Detection Based on Fluorescence Probe-Based Recombinase Polymerase Amplification. Food Analytical Methods. 12(8). 1791–1798. 12 indexed citations
20.
Guo, Zhengyang, Mingjie Yao, Yongfeng Wang, et al.. (2018). Diacylglycerol kinase γ predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma. Experimental Cell Research. 373(1-2). 211–220. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqin Zheng Breakdown of academic impact, for papers by Yinying Lu Breakdown of academic impact, for papers by Hongfei Chen Breakdown of academic impact, for papers by Haosheng Tang Breakdown of academic impact, for papers by Ian M. Cartwright Breakdown of academic impact, for papers by Fengqi Hao Breakdown of academic impact, for papers by Mladen Paradžik Breakdown of academic impact, for papers by Valesca Anschau Breakdown of academic impact, for papers by Manman Su
Rankless by CCL
2026